News

Welcome to the CLINUVEL News page. Discover the latest in clinical, corporate, and regulatory updates.

Chair’s letter to shareholders

2024 Announcements.Corporate.News

09.09.2024

CLINUVEL Board Renewal, Expansion

2024 Announcements . Corporate . News

06.09.2024

Appendix 3C – Notification of buy-back

2024 Announcements . Financial . News . Regulatory

05.09.2024

Appendix 3C – Notification of buy-back

2024 Announcements . Financial . News . Regulatory

04.09.2024

CLINUVEL Investor Webinar Financial Results – FY2024

2024 Announcements . Corporate . News

30.08.2024

Investor Presentation

2024 Announcements . Financial . News . Regulatory

29.08.2024

Appendix 4G and Corporate Governance Statement

2024 Announcements . Financial . News . Regulatory

29.08.2024

CLINUVEL delivers 16% NPAT increase

2024 Announcements . Financial . News . Regulatory

29.08.2024

Dividend/Distribution – CUV

2024 Announcements . Financial . News . Regulatory

29.08.2024

Appendix 4E & Annual Report

2024 Announcements . Financial . News . Regulatory

29.08.2024

Notice of ceasing to be a substantial holder

2024 Announcements . Financial . News . Regulatory

23.08.2024

Notice of initial substantial holder

2024 Announcements . Financial . News . Regulatory

22.08.2024

Vitiligo and Operational Update

2024 Announcements . Clinical . Corporate . News

21.08.2024

.

Go To Top